Trials / Completed
CompletedNCT07137169
LIMA Protocol Towards Palatal Fistula and Maxillary Growth in Cleft Palate
LIMA Protocol Towards Palatal Fistula and Maxillary Growth in Cleft Palate: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Indonesia University · Academic / Other
- Sex
- All
- Age
- 9 Months – 24 Months
- Healthy volunteers
- Not accepted
Summary
This randomized controlled trial compared palatoplasty outcomes using the LIMA protocol (Hybrid and one-flap techniques) versus the RSCM protocol (two-flap technique) in patients with unilateral Veau III-IV cleft palate at Cipto Mangunkusumo Hospital from January 2022 to December 2024.
Detailed description
Background: Palatoplasty in patients with cleft palate carries risks of palatal fistula and impaired maxillary growth, both of which are influenced by cleft severity and surgical technique. The LIMA protocol offers a refined classification and tailored surgical approach, with promising results in reducing these complications. Methods: This study is a randomized controlled trial comparing palatoplasty techniques based on the LIMA protocol (Hybrid and one-flap techniques) versus the RSCM protocol (two-flap technique) in terms of surgical outcomes: palatal fistula and maxillary growth. The study was conducted at Cipto Mangunkusumo Hospital (RSCM) from January 2022 to December 2024. Samples were collected consecutively, with all subjects who met the inclusion criteria (patients aged 9 months-2 years with unilateral Veau III-IV cleft palate undergoing primary palatoplasty at RSCM) randomly allocated into two study groups. Data were analyzed using T-test and Mann-Whitney U test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | LIMA protocol | Cleft palate repair using Hybrid / One-flap technique |
| PROCEDURE | RSCM Protocol | Cleft palate repair using Two-flap technique |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2025-08-22
- Last updated
- 2025-08-22
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT07137169. Inclusion in this directory is not an endorsement.